We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

By HospiMedica International staff writers
Posted on 22 May 2026

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams. More...

The platform is offered in two configurations—Elyra and Elyra Plus—to align with different operational requirements. It is engineered to support consistent performance across stone management and soft tissue procedures in high‑demand clinical settings.

The Elyra TFL System employs thulium fiber laser technology for stone dusting while aiming to reduce stone migration. An air‑cooled architecture is designed to provide quieter operation and a smaller footprint than traditional laser systems. For workflow efficiency, the system features an intuitive user interface, quick startup, and customizable presets; an optional wireless footswitch is available with Elyra Plus to further streamline stone lithotripsy and soft tissue procedures.

Initial clinical use has been completed with the Elyra Plus TFL System at a leading medical center, where urologists and laser technicians provided positive feedback. Users highlighted the intuitive interface and integrated safety features, noting benefits for ease of use and procedural confidence. The system extends BD’s urologic stone management portfolio across access, dilation, visualization, fragmentation, removal, and drainage to support an end‑to‑end approach.

“Elyra demonstrates how BD innovates with speed and purpose, introducing technology that helps clinicians deliver high‑quality care more efficiently,” said Mike Cusack, worldwide president of Urology and Critical Care at BD. “By pairing advanced TFL technology with a clinician‑focused design, Elyra streamlines kidney stone care and supports greater adaptability across diverse procedural needs,” added Mike Cusack, worldwide president of Urology and Critical Care at BD.



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Blood Gas Analyzer
i-Check200
Patient Preoperative Skin Preparation
BD ChloraPrep
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.